Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Study opens the door to a new approach to attacking herpesviruses

Study opens the door to a new approach to attacking herpesviruses

An algorithm to predict host cleavage targets of SARS-CoV-2 3CLPro

An algorithm to predict host cleavage targets of SARS-CoV-2 3CLPro

CENTOGENE teams up with Insilico Medicine to improve therapeutic targets for Niemann-Pick disease type C

CENTOGENE teams up with Insilico Medicine to improve therapeutic targets for Niemann-Pick disease type C

New cryo-EM method may be able to shortcut a big step in modern vaccine development

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Evaporators assist academic drug discovery

Evaporators assist academic drug discovery

Macrodomains represent a unique target for pathogens with pandemic potential

Macrodomains represent a unique target for pathogens with pandemic potential

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

PhoreMost expands into new facility at Unity Campus, Cambridge, UK

PhoreMost expands into new facility at Unity Campus, Cambridge, UK

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

TetraScience announces 300% ARR growth and 2021 achievements; prepares for next phase of growth

TetraScience announces 300% ARR growth and 2021 achievements; prepares for next phase of growth

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

AI-driven solution predicts RNA and DNA binding sites to accelerate rational drug discovery

NeoCura and PhoreMost Announce Research Collaboration   to Explore Novel Cancer Therapeutics

NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics

Providing recombinant antibody services and more within Europe

Providing recombinant antibody services and more within Europe

Therapeutic in vivo synthetic chemistry used to make anticancer drugs

Therapeutic in vivo synthetic chemistry used to make anticancer drugs

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

Research may pave the way for designing new therapies to combat schistosomiasis

Research may pave the way for designing new therapies to combat schistosomiasis

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

Empire Discovery Institute collaborates with Novo Nordisk to launch new drug discovery initiative

Empire Discovery Institute collaborates with Novo Nordisk to launch new drug discovery initiative